-
Joint ICMRA statement on continuation of vaccine trials
Joint ICMRA statement on continuation of vaccine trials
-
Joint ICMRA statement on continuation of vaccine trials
Joint ICMRA statement on continuation of vaccine trials
Global regulators urge stakeholders to continue clinical trials to generate additional and more precise information on longer-term safety and efficacy of vaccines against COVID-19.
-
PRAC meeting highlights 23-26 November 2020
PRAC meeting highlights 23-26 November 2020
-
PRAC meeting highlights 23-26 November 2020
PRAC meeting highlights 23-26 November 2020
PRAC review confirms link between use of chloroquine and hydroxychloroquine and risk of psychiatric disorders and suicidal behaviour.
-
Regulatory support for development of orphan medicines
Regulatory support for development of orphan medicines
-
Regulatory support for development of orphan medicines
Regulatory support for development of orphan medicines
Follow our webinar live on Monday, 30 November, 9:00 to 16:00 CET.
-
EMA organises public meeting on COVID-19 vaccines
EMA organises public meeting on COVID-19 vaccines
-
EMA organises public meeting on COVID-19 vaccines
EMA organises public meeting on COVID-19 vaccines
The meeting will take place on 11 December 2020 and will inform European citizens about the EU regulatory processes for the approval of COVID-19 vaccines.
